| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.26(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,033 |
| 52
Week Range: |
$6.53 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
| Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
2 |
4 |
7 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-28 |
4 |
D |
$24.44 |
$68,334 |
D/D |
(2,796) |
189,369 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2020-02-28 |
4 |
D |
$24.44 |
$175,161 |
D/D |
(7,167) |
309,581 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-02-28 |
4 |
D |
$24.44 |
$92,359 |
D/D |
(3,779) |
90,588 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2020-02-28 |
4 |
D |
$24.44 |
$21,238 |
D/D |
(869) |
82,801 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-02-28 |
4 |
D |
$24.44 |
$55,332 |
D/D |
(2,264) |
245,269 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-28 |
4 |
D |
$24.44 |
$61,076 |
D/D |
(2,499) |
81,802 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
63,030 |
316,748 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
19,449 |
192,165 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,753 |
83,670 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
19,449 |
94,367 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,506 |
247,533 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
81,040 |
936,774 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,506 |
84,301 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-02-20 |
4 |
D |
$26.46 |
$1,495,837 |
D/D |
(56,532) |
234,027 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2020-02-20 |
4 |
D |
$26.46 |
$236,632 |
D/D |
(8,943) |
76,917 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-20 |
4 |
D |
$26.46 |
$261,054 |
D/D |
(9,866) |
172,716 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-20 |
4 |
D |
$26.46 |
$309,661 |
D/D |
(11,703) |
70,795 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-02-20 |
4 |
D |
$26.46 |
$592,122 |
D/D |
(22,378) |
59,190 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-02-19 |
4/A |
OE |
$0.00 |
$0 |
D/D |
7,864 |
55,029 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
105,783 |
290,559 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,911 |
184,776 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
22,014 |
85,860 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2020-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,096 |
63,846 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
21,133 |
182,582 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,932 |
161,449 |
|
- |
|
705 Records found
|
|
Page 13 of 29 |
|
|
0.18 (2.75%) 
